SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

29 Jan 2025 Evaluate
The sales slipped to Rs. 94.51 millions for the December 2024 quarter as against Rs. 111.69 millions during the year-ago period.The Net Loss for the quarter ended December 2024 is Rs. -7.70 millions as compared to Net Loss of Rs. -19.46 millions of corresponding quarter ended December 2023 Operating profit Margin for the quarter ended December 2024 improved to 0.13% as compared to -9.94% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 94.51 111.69 -15.38 332.45 376.36 -11.67 490.89 425.47 15.38
Other Income 5.72 1.22 368.85 108.98 10.04 985.46 11.52 11.37 1.32
PBIDT 0.13 -9.94 -101.31 99.02 -26.18 -478.23 -26.09 -29.97 -12.95
Interest 1.33 4.19 -68.26 8.48 11.72 -27.65 16.34 13.81 18.32
PBDT -1.20 -14.13 -91.51 90.54 -37.90 -338.89 -42.43 -43.78 -3.08
Depreciation 7.28 6.83 6.59 21.54 20.32 6.00 27.15 23.99 13.17
PBT -8.48 -20.96 -59.54 69.00 -58.22 -218.52 -69.58 -67.77 2.67
TAX -0.78 -1.50 -48.00 8.57 -4.27 -300.70 -0.06 -4.15 -98.55
Deferred Tax -0.78 -1.50 -48.00 8.57 -4.27 -300.70 -0.04 -4.30 -99.07
PAT -7.70 -19.46 -60.43 60.43 -53.95 -212.01 -69.52 -63.62 9.27
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 59.00 0.00
PBIDTM(%) 0.14 -8.90 -101.55 29.78 -6.96 -528.18 -5.31 -7.04 -24.55

Makers Laboratories Share Price

155.80 -4.35 (-2.72%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×